Q-omics provides the consensus-scored RNU6-310P profile across patient tissues and cancer cell-line models. RNU6-310P expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in LIHC. Additionally, RNU6-310P RNA expression shows 8,442 significant gene co-expression associations, with the highest sampling consensus in LAML. Together, these results highlight LIHC, and LAML as cancer lineages where RNU6-310P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU6-310P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNU6-310P survival associations across molecular data types. RNU6-310P RNA expression shows survival associations in the most cancer types (13). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-310P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	13	LIHC (87)	view →

This table ranks reproducible RNU6-310P RNA expression–survival associations across cancer types. High RNU6-310P expression shows unfavorable associations in LIHC, UCEC, GBM, CESC, KICH and PAAD. The LIHC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LIHC as the clearest survival context for RNU6-310P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	II,III,IV	0.075	0.431	<.001	87	view →
UCEC	DFS	Tertile	All	0.259	0.651	<.001	54	view →
GBM	OS	Tertile	All	0.076	0.415	<.001	36	view →
CESC	OS	Tertile	All	0.550	0.804	.002	24	view →
KICH	DFS	Tertile	III,IV	0.035	0.772	.021	18	view →
PAAD	DFS	Tertile	All	0.140	0.508	.023	18	view →

Pink = unfavorable, green = favorable. all 13 lineages →

RNU6-310P-LIHC (DFS)

Kaplan–Meier survival curve for RNU6-310P RNA expression in LIHC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU6-310P in patient tissues and cancer cell lines. In patient samples, RNU6-310P shows the broadest associations at the RNA and protein expression levels, with LAML recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	8,442	LAML (3369)	view →
Function (RNA)	5,313	ESCA (3372)	view →